Prospective, multicentre trial evaluating FET-PET in Glioblastoma
The FIG trial is investigating how the addition of FET-PET imaging to standard MRI imaging affects radiation target volume delineation and treatment planning for Glioblastoma, as well as determining the accuracy and management impact of FET-PET in distinguishing pseudoprogression from true tumour progression and / or tumour recurrence.
Primary Sponsor
Collaborating Groups
COGNO, ARTnet, ONJCRI
Participating Centres
Accrual Target
210
Current Accrual
Trial Chairperson
Prof Andrew Scott - Olivia Newton-John Cancer Research Institute (ONJCRI) / The Austin Health, VIC
A/Prof Eng-Siew Koh - Liverpool Hospital, NSW
Trial Contact
FIG@trog.com.au
Clinical Trial Registration
Related Post
NINJA Radiation Therapy Trial participant tells his journey to treatment
The journey to becoming the 200th participant for the
The gift that kept on giving
The NewyWay Coffee Collaboration Newcastle marketing agency, The Marketing
